FABIOLA ALOUIDOR: Open Payments
NPI 1427627595 · BAY SHORE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 46 payments from 17 companies in 2025. Trend: 2023 $1,676 · 2024 $1,025 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $188 |
| AstraZeneca Pharmaceuticals LP | 4 | $185 |
| Amgen Inc. | 4 | $154 |
| ABBVIE INC. | 8 | $141 |
| Astellas Pharma US Inc | 4 | $84 |
| Exact Sciences Corporation | 3 | $80 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Amneal Pharmaceuticals LLC | 1 | $26 |
Products named: BREZTRI, EVENITY, Veozah, Cologuard Collection Kit, UBRELVY, Ozempic, GEMTESA, Kerendia.
Industry payments across NY — which companies pay providers there.
